Business Description
Dicot AB
ISIN : SE0011178458
Compare
Compare
Traded in other countries / regions
DICOT.SwedenKN0.GermanyDCOIF.USA IPO Date
2019-09-05Description
Dicot Pharma AB is developing a modern potency medicine that will treat erectile dysfunction and premature ejaculation better than existing preparations. The company's drug candidate LIB-01 has a longer duration of action and fewer side effects and also used in the treatment of erectile dysfunction and premature ejaculation.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.94 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 45.7 | |||||
| 3-Year EPS without NRI Growth Rate | 41.7 | |||||
| 3-Year FCF Growth Rate | 43.9 | |||||
| 3-Year Book Growth Rate | -42.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 16.76 | |||||
| Quick Ratio | 15.92 | |||||
| Cash Ratio | 15.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -128.3 | |||||
| Shareholder Yield % | -36.23 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -97.67 | |||||
| ROA % | -84.65 | |||||
| ROIC % | -685.34 | |||||
| ROC (Joel Greenblatt) % | -11087.56 | |||||
| ROCE % | -98.22 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.95 | |||||
| Price-to-Tangible-Book | 3.1 | |||||
| EV-to-EBIT | -4.86 | |||||
| EV-to-EBITDA | -4.86 | |||||
| EV-to-FCF | -4.69 | |||||
| Price-to-Net-Current-Asset-Value | 3.1 | |||||
| Price-to-Net-Cash | 3.1 | |||||
| Earnings Yield (Greenblatt) % | -20.58 | |||||
| FCF Yield % | -14.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with GREY:DCOIF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dicot AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0 - 0.47 | ||
| Shares Outstanding (Mil) | 43.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dicot AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dicot AB Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Dicot AB Frequently Asked Questions
What is Dicot AB(DCOIF)'s stock price today?
The current price of DCOIF is $0.47. The 52 week high of DCOIF is $0.47 and 52 week low is $0.00.
When is next earnings date of Dicot AB(DCOIF)?
The next earnings date of Dicot AB(DCOIF) is 2025-02-13.
Does Dicot AB(DCOIF) pay dividends? If so, how much?
Dicot AB(DCOIF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers